Influenza Vaccination as Secondary Prevention for Cardiovascular Disease
Davis MM, Taubert K, Benin AL, Brown DW, Mensah GA, Baddour LM, Dunbar S, Krumholz HM. Influenza Vaccination as Secondary Prevention for Cardiovascular Disease. Circulation 2006, 114: 1549-1553. PMID: 16982936, DOI: 10.1161/circulationaha.106.178242.Peer-Reviewed Original ResearchMeSH KeywordsAmerican Heart AssociationCardiovascular DiseasesHumansInfluenza VaccinesInfluenza, HumanTreatment OutcomeUnited StatesVaccinationConceptsCardiovascular diseaseSecondary preventionCardiovascular conditionsInfluenza vaccination coverage levelsInfluenza vaccination coverage ratesComprehensive secondary preventionAtherosclerotic vascular diseaseVaccination coverage ratesRandomized clinical trialsAmerican Heart AssociationVaccination coverage levelsCardiovascular morbidityCause mortalityInfluenza immunizationInfluenza vaccinationCohort studyInfluenza seasonInfluenza vaccineHeart AssociationAnnual vaccinationVascular diseaseClinical trialsAmerican CollegeCardiology practiceAttenuated vaccines